
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Advancements in the Treatment of Triple-Negative Breast Cancer: A Narrative Review of the Literature
Ian Landry, Vikram Sumbly, Mallorie Vest
Cureus (2022)
Open Access | Times Cited: 32
Ian Landry, Vikram Sumbly, Mallorie Vest
Cureus (2022)
Open Access | Times Cited: 32
Showing 1-25 of 32 citing articles:
The obesity-breast cancer link: a multidisciplinary perspective
Emily Devericks, Meredith S. Carson, Lauren E. McCullough, et al.
Cancer and Metastasis Reviews (2022) Vol. 41, Iss. 3, pp. 607-625
Open Access | Times Cited: 75
Emily Devericks, Meredith S. Carson, Lauren E. McCullough, et al.
Cancer and Metastasis Reviews (2022) Vol. 41, Iss. 3, pp. 607-625
Open Access | Times Cited: 75
Cancer Vaccines for Triple-Negative Breast Cancer: A Systematic Review
Mina Hosseini, Simin Seyedpour, Behzad Khodaei, et al.
Vaccines (2023) Vol. 11, Iss. 1, pp. 146-146
Open Access | Times Cited: 25
Mina Hosseini, Simin Seyedpour, Behzad Khodaei, et al.
Vaccines (2023) Vol. 11, Iss. 1, pp. 146-146
Open Access | Times Cited: 25
Triple Negative Breast Cancer Preclinical Therapeutic Management by a Cationic Ruthenium-Based Nucleolipid Nanosystem
Maria Grazia Ferraro, Marco Bocchetti, Claudia Riccardi, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6473-6473
Open Access | Times Cited: 17
Maria Grazia Ferraro, Marco Bocchetti, Claudia Riccardi, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6473-6473
Open Access | Times Cited: 17
Emerging targeted therapeutic strategies for the treatment of triple-negative breast cancer
Lakshmi Kumari, Lopamudra Mishra, Preeti Patel, et al.
Journal of drug targeting (2023) Vol. 31, Iss. 9, pp. 889-907
Closed Access | Times Cited: 16
Lakshmi Kumari, Lopamudra Mishra, Preeti Patel, et al.
Journal of drug targeting (2023) Vol. 31, Iss. 9, pp. 889-907
Closed Access | Times Cited: 16
Update on Classic and Novel Approaches in Metastatic Triple-Negative Breast Cancer Treatment: A Comprehensive Review
Salvatore Greco, Nicolò Fabbri, Riccardo Spaggiari, et al.
Biomedicines (2023) Vol. 11, Iss. 6, pp. 1772-1772
Open Access | Times Cited: 10
Salvatore Greco, Nicolò Fabbri, Riccardo Spaggiari, et al.
Biomedicines (2023) Vol. 11, Iss. 6, pp. 1772-1772
Open Access | Times Cited: 10
Prodelphinidin from Purple Sweet Potato Induces Apoptosis in Human Triple-Negative Breast Cancer Cells via Reactive Oxygen Species and Endoplasmic Reticulum Stress Through the Mitochondrial Apoptosis Pathways
Jie Zhang, Zihan Chen, Shibo Wang, et al.
Research Square (Research Square) (2025)
Open Access
Jie Zhang, Zihan Chen, Shibo Wang, et al.
Research Square (Research Square) (2025)
Open Access
EGFR-to-Src family tyrosine kinase switching in proliferating-DTP TNBC cells creates a hyperphosphorylation-dependent vulnerability to EGFR TKI
Nazia Chaudhary, Bhagya Shree Choudhary, Anusha Shivashankar, et al.
Cancer Cell International (2025) Vol. 25, Iss. 1
Open Access
Nazia Chaudhary, Bhagya Shree Choudhary, Anusha Shivashankar, et al.
Cancer Cell International (2025) Vol. 25, Iss. 1
Open Access
Prodelphinidin from purple sweet potato induces apoptosis in human triple-negative breast cancer cells via ROS-mediated ER stress activation
Jie Zhang, Zihan Chen, Shibo Wang, et al.
Medical Oncology (2025) Vol. 42, Iss. 4
Closed Access
Jie Zhang, Zihan Chen, Shibo Wang, et al.
Medical Oncology (2025) Vol. 42, Iss. 4
Closed Access
Carcinoma arising in microglandular adenosis of the breast: clinicopathological and genetic analysis
Qiang Zhang, Yanping Li, Baohua Yu, et al.
Journal of Clinical Pathology (2025), pp. jcp-209833
Closed Access
Qiang Zhang, Yanping Li, Baohua Yu, et al.
Journal of Clinical Pathology (2025), pp. jcp-209833
Closed Access
QbD assisted development of hyaluronic acid and TPGS incorporated DOX liposome(s): in vitro assessment of cytotoxicity, uptake, ROS, and NF-κB potential on MDA-MB-231 cells
Lakshmi Kumari, Rajveer Singh, Preeti Patel, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Lakshmi Kumari, Rajveer Singh, Preeti Patel, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Liposomal oncolytic adenovirus as a neoadjuvant therapy for triple-negative breast cancer
Jaimin R. Shah, Tao Dong, Abraham T. Phung, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Jaimin R. Shah, Tao Dong, Abraham T. Phung, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Evaluation of the Histone Deacetylase 2 (HDAC-2) Expression in Human Breast Cancer
Christos Damaskos, Iason Psilopatis, Anna Garmpi, et al.
Cancers (2024) Vol. 16, Iss. 1, pp. 209-209
Open Access | Times Cited: 3
Christos Damaskos, Iason Psilopatis, Anna Garmpi, et al.
Cancers (2024) Vol. 16, Iss. 1, pp. 209-209
Open Access | Times Cited: 3
Tumor therapy by targeting extracellular hydroxyapatite using novel drugs: A paradigm shift
Mohammed Noor Tantawy, J. Oliver McIntyre, Fiona E. Yull, et al.
Cancer Medicine (2024) Vol. 13, Iss. 3
Open Access | Times Cited: 2
Mohammed Noor Tantawy, J. Oliver McIntyre, Fiona E. Yull, et al.
Cancer Medicine (2024) Vol. 13, Iss. 3
Open Access | Times Cited: 2
The Role of Patient-Derived Organoids in Triple-Negative Breast Cancer Drug Screening
Iason Psilopatis, Amalia Mantzari, Kleio Vrettou, et al.
Biomedicines (2023) Vol. 11, Iss. 3, pp. 773-773
Open Access | Times Cited: 6
Iason Psilopatis, Amalia Mantzari, Kleio Vrettou, et al.
Biomedicines (2023) Vol. 11, Iss. 3, pp. 773-773
Open Access | Times Cited: 6
Chlorin Conjugates in Photodynamic Chemotherapy for Triple-Negative Breast Cancer
Meden F. Isaac-Lam
Pharmaceuticals (2024) Vol. 17, Iss. 5, pp. 576-576
Open Access | Times Cited: 1
Meden F. Isaac-Lam
Pharmaceuticals (2024) Vol. 17, Iss. 5, pp. 576-576
Open Access | Times Cited: 1
Association of high miR-27a, miR-206, and miR-214 expression with poor patient prognosis and increased chemoresistance in triple-negative breast cancer.
Yueyang Liu, Weiwei Gong, Konstantina Panoutsopoulou, et al.
PubMed (2023) Vol. 13, Iss. 6, pp. 2471-2487
Closed Access | Times Cited: 3
Yueyang Liu, Weiwei Gong, Konstantina Panoutsopoulou, et al.
PubMed (2023) Vol. 13, Iss. 6, pp. 2471-2487
Closed Access | Times Cited: 3
A Holistic Approach to Hard-to-Treat Cancers: The Future of Immunotherapy for Glioblastoma, Triple Negative Breast Cancer, and Advanced Prostate Cancer
Carles Puig-Saenz, Joshua R. D. Pearson, Jubini E. Thomas, et al.
Biomedicines (2023) Vol. 11, Iss. 8, pp. 2100-2100
Open Access | Times Cited: 3
Carles Puig-Saenz, Joshua R. D. Pearson, Jubini E. Thomas, et al.
Biomedicines (2023) Vol. 11, Iss. 8, pp. 2100-2100
Open Access | Times Cited: 3
EGFR-to-Src family tyrosine kinase switching in proliferating-DTP TNBC cells creates a hyperphosphorylation-dependent vulnerability to EGFR TKI
Nazia Chaudhary, Bhagya Shree Choudhary, Anusha Shivashankar, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Nazia Chaudhary, Bhagya Shree Choudhary, Anusha Shivashankar, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
A novel treatment to enhance survival for end stage triple negative breast cancer using repurposed veterinary anthelmintics combined with gut‑supporting/immune enhancing molecules
Vijaya Iragavarapu‐Charyulu, R Shakya, Philip Robinson, et al.
Oncology Reports (2023) Vol. 51, Iss. 2
Closed Access | Times Cited: 1
Vijaya Iragavarapu‐Charyulu, R Shakya, Philip Robinson, et al.
Oncology Reports (2023) Vol. 51, Iss. 2
Closed Access | Times Cited: 1
Advances in RNA therapeutics for modulation of ‘undruggable’ targets
Emily Martinsen, Tasmia Jinnurine, Saranya Subramani, et al.
Progress in molecular biology and translational science (2024), pp. 249-294
Closed Access
Emily Martinsen, Tasmia Jinnurine, Saranya Subramani, et al.
Progress in molecular biology and translational science (2024), pp. 249-294
Closed Access
Oleate Promotes Triple-Negative Breast Cancer Cell Migration by Enhancing Filopodia Formation through a PLD/Cdc42-Dependent Pathway
Zhiqiang Guo, Karl‐F. Bergeron, Cathérine Mounier
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3956-3956
Open Access
Zhiqiang Guo, Karl‐F. Bergeron, Cathérine Mounier
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3956-3956
Open Access
Primary Care and Surgical Collaborations in Addressing Breast Cancer: A Comprehensive Review
Anuoluwa Oyetoran, Samantha Sircar, Oluwadamilola T. Oladeru, et al.
Current Breast Cancer Reports (2024) Vol. 16, Iss. 3, pp. 359-364
Open Access
Anuoluwa Oyetoran, Samantha Sircar, Oluwadamilola T. Oladeru, et al.
Current Breast Cancer Reports (2024) Vol. 16, Iss. 3, pp. 359-364
Open Access
Facilitating patient-oncologist communication in advanced treatment-resistant cancer: development and feasibility testing of a question prompt list.
Aude Rault, Sylvie Dolbeault, Johanna Terrasson, et al.
Research Square (Research Square) (2024)
Open Access
Aude Rault, Sylvie Dolbeault, Johanna Terrasson, et al.
Research Square (Research Square) (2024)
Open Access
Facilitating patient-oncologist communication in advanced treatment-resistant cancer: development and feasibility testing of a question prompt list
Aude Rault, Sylvie Dolbeault, Johanna Terrasson, et al.
Pilot and Feasibility Studies (2024) Vol. 10, Iss. 1
Open Access
Aude Rault, Sylvie Dolbeault, Johanna Terrasson, et al.
Pilot and Feasibility Studies (2024) Vol. 10, Iss. 1
Open Access
Mass Spectrometry-Based Proteomics for Classification and Treatment Optimisation of Triple Negative Breast Cancer
Essraa metwali, Stephen R. Pennington
Journal of Personalized Medicine (2024) Vol. 14, Iss. 9, pp. 944-944
Open Access
Essraa metwali, Stephen R. Pennington
Journal of Personalized Medicine (2024) Vol. 14, Iss. 9, pp. 944-944
Open Access